Accelerate molecular research at AACR 2019

AACR 2019 Blog Image

Organized by the American Association for Cancer Research, the AACR Annual Meeting 2019 is an immense gathering of the world’s most renowned oncologists and medical professionals excelling in every aspect of cancer sciences and research – and it’s approaching rapidly.

As cancer is a highly complex disease, understanding the various alterations that together determine disease onset, progression, recurrence and response to treatment, is of fundamental importance. Deep understanding of the biological mechanisms is needed to deconstruct cancer’s complexity. Relevant biomarkers can be used as landmarks for navigating this biological complexity, anchoring targeted treatment programs. Comprehensive biomarker profiling studies are needed to provide an accurate foundation for actionable real-world insights.

Cancer research matters to everyone

That’s why we are excited to display trusted tools that enable unprecedented insights into the biology of cancer – from Sample to Insight  – in Atlanta, Georgia, from March 31 to April 3.

Visit us at our Booth #3106 and discover new ways to accelerate your cancer research: Learn more about trusted solutions for rapid RNA biomarker discoveries, no matter whether you’re interested in biofluid sample stabilization and isolation, gene expression profiling or transcriptome analysis – we’ll find solutions to accelerate your research. You can also immerse yourself in virtual reality to discover the world of redefined automated sample processing. If you are aiming to understand what changes in the genome of cancer cells cause them to become malignant, we’ve got Sample to Insight solutions to help you make breakthrough discoveries that lead to better understanding of cancer.

Visit the AACR Spotlight Theater on Tuesday, April 2, 2019 at 12:30–1:30 p.m. in Theater A, Hall B1. Join Ravi Kohle, MD, Associate Professor of Pathology and Medical Director of Cytogenetics Laboratory and Esoteric & Molecular Laboratory for his talk “Deconstructing the complexity: Tailored Sample to Insight tools that put your data into action.” Afterwards, John A. Martignetti MD, PhD, Professor of Genetics and Genomic Sciences, Obstetrics, Gynecology and Reproductive Science will take over and talk about “An unusual tumor evolution and a rare sarcoma: genomic analysis of gynecologic cancer cases using QIAGEN bioinformatic solutions to advance patient care.”

It’s the insights that count – let’s work to conquer cancer. Together.

Laura Alina Mohr, M.Sc.

Laura Alina Mohr joined QIAGEN in 2015. She received her Master’s Degree in Chemical Biology at the Technical University Dortmund in Germany. During this time, she was involved in Systemic Cell Biology research at the prestigious Max Planck Institute. Before joining QIAGEN, Laura Alina worked at the Scripps Research Institute, San Diego, where she first focused on DNA damage/repair pathways and telomere biology. Later, she joined the Muscle Development, Aging and Regeneration program at the Sanford Burnham Prebys Medical Discovery Institute. At QIAGEN she is interested in gene expression profiling focusing on various biological pathways, e.g. cancer research and neurodegeneration.

Your email address will not be published. Required fields are marked *